v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net cash provided by operating activities:    
Net income (loss) $ 8,694 $ 4,464
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion, and amortization 7,708 7,199
Deferred income tax benefit   (827)
Gain on sale of real estate, property and equipment and assets held for sale (3,347) (2,863)
Impairment of right-of-use asset   87
Loss on disposal of long-lived assets 1,200 723
Stock-based compensation expense 630 790
Other   (36)
Changes in operating assets and liabilities:    
Accounts receivable (6,662) (3,672)
Inventories 10,820 11,640
Prepaid expenses (259) (234)
Income tax receivable 781  
Other assets 278 (387)
Accounts payable and accrued liabilities 5,623 (2,061)
Income taxes payable 888 (2,876)
Other liabilities (728) (259)
Net cash provided by operating activities 25,626 11,688
Cash flows from investing activities:    
Purchases of property and equipment (10,336) (9,960)
Acquisition of citrus grove (18,230)  
Net proceeds from sale of real estate, property and equipment and assets held for sale 3,442 2,994
Change in deposits on purchase of citrus trees 240 (57)
Advances on notes receivables, net 271 87
Other 15 (25)
Net cash used in investing activities (24,598) (6,961)
Cash flows from financing activities:    
Repayments on revolving lines of credit (45,247) (18,805)
Borrowings on revolving lines of credit 42,305 85,519
Principal payments on term loans (5,377) (9,820)
Treasury stock purchases   (238)
Dividends paid (2,025) (1,120)
Deferred financing costs   (23)
Net cash (used in) provided by financing activities (10,344) 55,513
Net (decrease) increase in cash and cash equivalents and restricted cash (9,316) 60,240
Cash and cash equivalents and restricted cash at beginning of the period 19,687 23,838
Cash and cash equivalents and restricted cash at end of the period $ 10,371 $ 84,078

Source